Clinical Trial Update: CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine [Phase 3]

View source ↗

Summary

A Phase 3 trial (CMP-MYTHiC) evaluating colchicine therapy for cardiomyopathy with myocarditis is currently recruiting. Sponsor: Niguarda Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure
• Inflammatory Cardiomyopathy
• Myocarditis
• Ventricular Arrhythmia

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Niguarda Hospital | Conditions: Cardiomyopathies, Myocarditis | Phase 3 | Status: RECRUITING